Inclusion Criteria:  All patients with written informed consent who are eligible for flecainide treatment for atrial fibrillation. The patients must be followed at the Skånes hospitals northwest and Skånes university hospitals. Age >18 years  Exclusion Criteria:  Flecainide treatment with other indication than atrial fibrillation (including atrial flutter). No secure date for treatment start. Age <18 years